LAUSR

Protective Cancer Vaccine Using Genetically Modified Hematopoietic Stem Cells

Sign Up to like & get
recommendations!
0 Published in 2018 at "Vaccines"

DOI: 10.3390/vaccines6030040

Abstract: Hematopoietic stem cells (HSCs) yield both the myeloid and lymphoid lineages of blood cells and can be reprogrammed into tumor antigen (Ag)-specific CD8+ cytotoxic T lymphocytes (CTLs) to prevent tumor growth. However, the optimal approach… read more here.

Keywords: protective cancer; genetically modified; hematopoietic stem; using genetically ... See more keywords